Tabassum, N., & Yasmin, H. (2024). Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: A pharmacovigilance study. Brac University.
Cita Chicago Style (17a ed.)Tabassum, Nadira, y Hasina Yasmin. Gender-specific Rhabdomyolysis Risk in Alzheimer’s Disease Patients Receiving Memantine: A Pharmacovigilance Study. Brac University, 2024.
Cita MLA (8a ed.)Tabassum, Nadira, y Hasina Yasmin. Gender-specific Rhabdomyolysis Risk in Alzheimer’s Disease Patients Receiving Memantine: A Pharmacovigilance Study. Brac University, 2024.
Precaución: Estas citas no son 100% exactas.